AstraZeneca and Oxford defend Covid vaccine trials after questions raised in the U.S.

“We believe that this product will never be licensed in the U.S.,” one group of critical U.S.-based analysts wrote this week.

from Health and Science https://ift.tt/366eBDe
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH